l6l 



-19^6- 

 TUCKER, J. 



Typhoid shock therapy- 

 Cleveland Clin. Quart. 13:67-72^ 19^6 



Experiences with fever elicited by typhoid vaccine in several 

 thousand patients during the past 15 years have been useful for 

 deterrainlng correct applications and contraindications for 

 typhoid shock therapy. Most successful results have been rea- 

 lized in the following conditions: central nervous system 

 virus Infections, chronic rheumatoid arthritis, chorea, and eye 

 and skin diseases. 



WARREN, M. R. and WERNER, H, W, 



The evaluation of antipyretics against pyrogen-induced fever 



J. Am. Pharm. A. 35:257-259^ 19^6 



A purified pyrogen was prepared from Proteus vulgaris by cellular 

 lysis, repeated phenol extraction, dialysis and acetone precipi- 

 tation. The minimal pyrogenic dose was 0.5 cc • per kg. body 

 weight in the rabbit when the pyrogen was injected subcutaneously . 

 Temperature was reduced to normal levels by the oral administra- 

 tion of amlnopyrene, acetanilid or acetylsalicylic acid; aceto- 

 phenetidln arrested temperature Increase but did not reduce fever. 



WEENS, H. S. and HEYMAN, A, 



Cardiac enlargement in fever therapy Induced by intravenous in- 

 jection of typhoid vaccine 



Arch. Int. Med, 77:307-316, 19^^6 



Enlargement of the heart during typhoid vaccine therapy was noted 

 In 8 of 15 patients with neurosyphilis. In four other patients, 

 cardiac changes persisted for six months following hyperpyrexia. 

 No sigrllflcant differences could be found between patients with 

 normal cardiac size and those with enlarged structures. Blood 

 volume, cardiac output, and protein and hemoglobin levels did not 

 differ widely from the norm. 



WESTPALL, B. B. and DUNN, T. E, 



Blood uric acid and proteose, body temperature and glomerular 

 clearance of rabbits Implanted with the Brown-Pearce carcinoma 

 and treated with the polysaccharide from Serratia marcescens 



J. Nat. Cancer Inst. 7:115-121, 19^6 



